Justin West is a physician and father of three. His youngest son, Andrew, was diagnosed with KCNT1-related epilepsy at 9 months of age. He is director of clinical medicine at the KCNT1 Epilepsy Foundation, working with researchers and industry to identify and evaluate potential therapeutics.
Justin West
President and director of clinical medicine
KCNT1 Epilepsy Foundation
From this contributor
Progress amid setbacks in drug trials for rare forms of epilepsy: Q&A with Justin West
Despite grave side effects, it’s vital to keep developing treatments for rare genetic forms of childhood epilepsy, says West, president of the KCNT1 Epilepsy Foundation and father of a son with the condition.
Progress amid setbacks in drug trials for rare forms of epilepsy: Q&A with Justin West
Explore more from The Transmitter
Finding neuroheterogeneity’s sweet spot
Once thought to be detrimental to memory processing, neuronal diversity—at the right ‘Goldilocks’ dose—is a new boon to theoretical neuroscience.
Finding neuroheterogeneity’s sweet spot
Once thought to be detrimental to memory processing, neuronal diversity—at the right ‘Goldilocks’ dose—is a new boon to theoretical neuroscience.
COVID-19 and influenza effects in pregnancy; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 19 October.
COVID-19 and influenza effects in pregnancy; and more
Here is a roundup of autism-related news and research spotted around the web for the week of 19 October.
What to do when traditional mechanistic approaches no longer work
Many complex behaviors have stubbornly resisted mechanistic explanations. Deciphering them will require new approaches—and perhaps a new concept of “understanding.”
What to do when traditional mechanistic approaches no longer work
Many complex behaviors have stubbornly resisted mechanistic explanations. Deciphering them will require new approaches—and perhaps a new concept of “understanding.”